When was ARCH founded?

ARCH was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is ARCH located?

ARCH is headquartered in Chuo City, Japan.

Is ARCH a funded company?

ARCH is a funded company, having raised a total of $7.49M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 17, 2022.

When was the latest funding round of ARCH?

ARCH's latest funding was a $***** Series A round on Nov 26, 2024, with participation from 8 investors. Its primary sector is Services for Healthcare Providers. Globally, the Services for Healthcare Providers sector has seen $521M in funding in 2026 to date.

Where does ARCH rank among its competitors?

ARCH ranks 19th amongst 346 active competitors, of which 25 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Alveolus Bio, which secured an undisclosed amount in Aug, 2025.

Who are the top competitors of ARCH?

ARCH's top competitors include Sibel Health, Agiliti and Alveolus Bio. Among them, Alveolus Bio secured the most recent funding round in August, 2025.

ARCH - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: www.arch.social/
Email ID: *****@arch.social
Phone Number: +81 **********

Key Metrics

Founded Year

2021

Location

Chuo City, Japan

Stage

Series A

Total Funding

$7.49M in 2 rounds

Latest Funding Round

Series A, Nov 26, 2024, $*****

Investors

ANRI & 8 more

Ranked

19^th among 346 active competitors

Similar Companies

Sibel Health & 354 more

View ARCH's full profile

ARCH has raised a total funding of $7.49M over 2 rounds. Its first funding round was on Nov 17, 2022. Its latest funding round was a Series A round on Nov 26, 2024 for $*****. 8 investors participated in its latest round. ARCH has 9 institutional investors.

Here is the list of recent funding rounds of ARCH:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Nov 26, 2024	7080113	Series A	1143926	3411460	9046448	7636831
Nov 17, 2022	1526390	Seed	3226602	9534209	XTech Ventures & 2 more	1762508

Access funding benchmarks and valuations. Sign up today!

View details of ARCH's funding rounds and investors

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ARCH include Sibel Health, Agiliti and Alveolus Bio. Here is the list of Top 10 competitors of ARCH, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Sibel Health 2018, Niles (United States), Series C	Developer of wireless medical monitoring devices for clinical and remote use	$71M	Steele Foundation for Hope, JLABS & 5 others	62/100
2nd	Agiliti 1939, Minneapolis (United States), Public	Provider of medical equipment management services	-	Harbour Point Capital	52/100
3rd	Alveolus Bio 2021, Birmingham (United States), Seed	Provider of biotherapeutics services for lung diseases treatment	-	Lumira Ventures, Shilpa Medicare & 2 others	46/100
4th	TEAM Technologies 1988, Morristown (United States), Acquired	Manufacturer of medical devices and dental products	-	Riverside	40/100
5th	Bastide 1977, Caissargues (France), Unfunded	Provider of home healthcare products and services for patients and healthcare facilities	-	-	39/100
6th	Althea 2017, Rodano (Italy), Acquired	Provider of healthcare consulting, outsourced imaging, and managed equipment services	-	Europa	38/100
7th	Corza 2021, Westwood (United States), Unfunded	Provider of surgical medical devices	-	-	37/100
8th	Sterima 2000, Kortrijk (Belgium), Acquired	Provider of sterilizing medical equipment	-	-	36/100
9th	NRS Healthcare Services 1947, Coalville (United Kingdom), Acquired	Provider of medical equipment support services	-	Graphite Capital	35/100
10th	Samaritan Bio 2024, Bengaluru (India), Unfunded	Developer of urine analysis system for acute and chronic kidney disease	-	-	35/100
19th	ARCH 2021, Chuo City (Japan), Series A	Provider of support system specializing in gynecology and infertility treatment	$7.49M	Dai-Ichi Life, ANRI & 7 others	30/100